BIBLIOGRAPHIC RECORD
Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program
This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.
- Recorded authors
- Jolien K. E. Veraart; Sanne Y. Smith-Apeldoorn; Annemarie van der Meij; Jan Spijker; Robert A. Schoevers; Jeanine Kamphuis
- Source of metadata
- OpenAlex
- Year recorded
- 2025
Public identifiers and source
Open the source recordReference
Jolien K. E. Veraart; Sanne Y. Smith-Apeldoorn; Annemarie van der Meij; Jan Spijker; Robert A. Schoevers; Jeanine Kamphuis. (2025). Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program. https://openalex.org/W4409845273
Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.
Permanent record URL: https://brain.psiconautica.org/en/documentos/d-83d4b1b6282db6e828432e984f38b3ca/